opli key statistics  ophthalix inc financial ratios  marketwatch bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close ophthalix inc otc opli go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus ophthalix inc market closed  quotes are delayed by  min jun    pm opli quoteszigmandelayed   change   volume volume  quotes are delayed by  min quoteszigmandelayed previous close     change   day low day high    week low  week high   company description ophthalix inc is a clinicalstage biopharmaceutical company which engages in the research and development of therapeutic products for ophthalmic disorders its portfolio includes cf oral drug that intends to treat glaucoma and uveitis the company was founded by ilan cohn on december    ophthalix inc is a clinicalstage biopharmaceutical company which engages in the research and development of therapeutic products for ophthalmic disorders its portfolio includes cf oral drug that intends to treat glaucoma and uveitis the company was founded by ilan cohn on december   and is headquartered in petach tikva israel valuation pe current  pe ratio with extraordinary items  enterprise value to ebitda  total debt to enterprise value  efficiency liquidity current ratio  quick ratio  cash ratio  profitability return on assets  return on total capital 8 capital structure total debt to total capital  total debt to total assets 8 officers and executives name age officer since title dr pnina fishman   chairman  chief executive officer mr itay weinstein   chief financial officer mr guy regev   director dr ilan cohn   vice chairman mr ronen kantor   secretary insider actions – purchase – sale  – number of transactions for more information visit the ft lexiconlexicon on this pageexplore our toolsalertsdata archiveportfolioworld marketsequities screenerfunds overview  thomson reuters click for restrictions all markets data located on ftcom is subject to the ft terms  conditionsall content on ftcom is for your general information and use only and is not intended to address your particular requirements in particular the content does not constitute any form of advice recommendation representation endorsement or arrangement by ft and is not intended to be relied upon by users in making or refraining from making any specific investment or other decisionsany information that you receive via ftcom is at best delayed intraday data and not real time share price information may be rounded updown and therefore not entirely accurate ft is not responsible for any use of content by you outside its scope as stated in the ft terms  conditions welcome to the ftcom markets data we’re constantly improving and would like to hear from you provide feedback   opli profile  ophthalix inc stock  yahoo financehomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoreyahoosearchsearchus markets closedsp  dow 8 listenaetnas ceo mark bertolini on the future of the health care systembertolini shares how a lifethreatening injury shaped his views on health careophthalix inc opliother otc  other otc delayed price currency in usdadd to watchlist at close pm edtpeople also watchombpcanfogenorgsonbisummaryconversationsstatisticsprofilefinancialsoptionsholdershistorical dataanalystsophthalix inc bareket streetpetach tikva 8israel   httpwwwophthalixcomsector healthcareindustry biotechnologyfull time employees key executivesnametitlepayexercisedageprof pnina fishman phdchairman  chief exec officernanamr itay weinsteinchief financial officer8knamr ronen kantor advsecnananadr william d kerns dvm ms dacvpvp of drug develnananadr michael h silverman md facpfacrmedical directornananaamounts are as of december   and compensation values are for the last fiscal year ending on that date pay is salary bonuses etc exercised is the value of options exercised during the fiscal year currency in usddescriptionophthalix inc does not have significant operations previously it was engaged in the development of therapeutic products for the treatment of ophthalmic disorders the company was founded in  and is based in petach tikva israel ophthalix inc is a subsidiary of canfite biopharma ltdcorporate governanceophthalix inc’s iss governance qualityscore as of na is na the pillar scores are audit na board na shareholder rights na compensation nacorporate governance scores courtesy of institutional shareholder services iss scores indicate decile rank relative to index or region a decile score of  indicates lower governance risk while a  indicates higher governance riskyahoo small businessdata disclaimerhelpsuggestionsprivacyabout our adsterms updated opli stock price  news  ophthalix inc  wall street journal dow jones a news corp company news corp is a network of leading companies in the worlds of diversified media news education and information services dow jones barrons bigcharts djx dow jones newswires factiva financial news mansion global marketwatch newsmart newsplus private markets risk  compliance wsjcom wsj pro wsj conference wsj video news corp big decisions business spectator checkout harper collins new york post proptiger rea realtorcom storyful the australian the sun the times djia ▲ 8    sp  ▲     nasdaq ▲ 8    us  yr ▲  yield    crude oil ▲  8   euro ▲     subscribe now sign in the wall street journal us edition us asia europe india  china  japan july   todays paper sections my journal home world us politics economy business tech markets opinion arts life real estate todays paper show all sections hide all sections world home africa asia canada china europe latin america middle east economy world video us home economy law new york politics real time economics washington wire journal report us video whats news podcast politics home washington wire politics video wsjnbc news poll economy home real time economics economic forecasting survey economy video business home management techwsjd aerospace  defense autos  transportation commercial real estate consumer products energy entrepreneurship financial services food  services health care hospitality law manufacturing media  marketing natural resources retail cfo journal cio journal cmo today logistics report risk  compliance heard on the street business video journal report business podcast tech home cio journal geoffrey fowler christopher mims joanna stern li yuan billion dollar startup club tech video tech podcast startup stock trader markets home bonds commercial real estate commodities  futures currencies deals financial services funds stocks your money heard on the street moneybeat wealth adviser ahead of the tape cfo journal journal report market data markets video markets podcast moneybeat podcast watching your wealth podcast opinion home james freeman william a galston daniel henninger holman w jenkins william mcgurn peggy noonan mary anastasia ogrady jason riley kimberley a strassel books film television theater art masterpiece series music dance opera exhibition cultural commentary editorials commentary letters to the editor the weekend interview potomac watch podcast foreign edition podcast opinion video notable  quotable best of the web newsletter morning editorial report newsletter arts home books film television theater art masterpiece series arts video wsj magazine life home careers cars food  drink health ideas real estate science sports style  fashion travel life video wsj magazine wsj puzzles the future of everything real estate home commercial real estate house of the day mansion real estate video hide all sections aim higher reach further get the wall street journal  for  weeks subscribe now sign in reveal navigation options subscribe sign in ophthalix inc opli us otc search view all companies at close  pm edt   usd   volume  volume   day avg vol   day range     week range        d  d  m  m ytd  y  y   advanced charting compare compare to benchmark djia sp  global dow nasdaq health carelife sciences compare to add open  prior close    day opli  djia  russell k  health carelife sciences  overview overview profile financials income statement balance sheet cash flow research  ratings historical prices options advanced charting news ophthalix incopli no news for opli in the past two years key stock data  pe ratio ttm the price to earnings pe ratio a key valuation measure is calculated by dividing the stocks most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing  month period earnings per share ttm a companys net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding market capitalization reflects the total market value of a company market cap is calculated by multiplying the number of shares outstanding by the stocks price for companies with multiple common share classes market capitalization includes both classes shares outstanding number of shares that are currently held by investors including restricted shares owned by the companys officers and insiders as well as those held by the public public float the number of shares in the hands of public investors and available to trade to calculate start with total shares outstanding and subtract the number of restricted shares restricted stock typically is that issued to company insiders with limits on when it may be traded dividend yield a companys dividend expressed as a percentage of its current stock price key stock data pe ratio ttm na eps ttm  market cap 8 m shares outstanding  m public float 8 m yield opli has not issued dividends in more than  year latest dividend na exdividend date na  shares sold short the total number of shares of a security that have been sold short and not yet repurchased change from last percentage change in short interest from the previous report to the most recent report exchanges report short interest twice a month percent of float total short positions relative to the number of shares available to trade short interest  na  money flow uptickdowntick ratio money flow measures the relative buying and selling pressure on a stock based on the value of trades made on an uptick in price and the value of trades made on a downtick in price the updown ratio is calculated by dividing the value of uptick trades by the value of downtick trades net money flow is the value of uptick trades minus the value of downtick trades our calculations are based on comprehensive delayed quotes stock money flow na advertisement competitors opli company change pe ttm psti pluristem therapeutics inc    sdon sandston corp    rdhl redhill biopharma ltd adr    adhd alcobra ltd    xtlb xtl biopharmaceuticals ltd adr    more information on opli competitor data provided by capital cube profile opli ophthalix inc is a clinicalstage biopharmaceutical company which engages in the research and development of therapeutic products for ophthalmic disorders its portfolio includes cf oral drug that intends to treat glaucoma and uveitis the company was founded  bareket street petach tikva ta 8 israel website map employees  sector biotechnology sales or revenue  industry health carelife sciences y sales change  fiscal year ends december  download reports pnina fishman chairman  chief executive officer itay weinstein chief financial officer guy regev director ilan cohn vice chairman more research  ratings ophthalix incopli pershare earnings actuals and estimates data not available financials ophthalix incopli quarterly annual net income       mar  jun  sep  dec  mar    8 m m m      mar  quarter trend net income growth  sales or revenue  sales or revenue growth  ebitda 8  year trend net income growth 8 sales or revenue  sales or revenue growth  ebitda  more overview notes  data providers realtime us stock quotes reflect trades reported through nasdaq only international stock quotes are delayed as per exchange requirements indexes may be realtime or delayed refer to time stamps on index quote pages for information on delay times quote data except us stocks provided by six financial information data is provided as is for informational purposes only and is not intended for trading purposes six financial information a does not make any express or implied warranties of any kind regarding the data including without limitation any warranty of merchantability or fitness for a particular purpose or use and b shall not be liable for any errors incompleteness interruption or delay action taken in reliance on any data or for any damages resulting therefrom data may be intentionally delayed pursuant to supplier requirements all of the mutual fund and etf information contained in this display was supplied by lipper a thomson reuters company subject to the following copyright  thomson reuters all rights reserved any copying republication or redistribution of lipper content including by caching framing or similar means is expressly prohibited without the prior written consent of lipper lipper shall not be liable for any errors or delays in the content or for any actions taken in reliance thereon bond quotes are updated in realtime source tullett prebon currency quotes are updated in realtime source tullet prebon fundamental company data and analyst estimates provided by factset copyright factset research systems inc all rights reserved advertisement